ClinicalTrials.gov
public full text
Public Domain
Omega-3 Dietary Supplements in Schizophrenia
This 16-week placebo-control study looks to investigate whether patients with schizophrenia for two years or less may benefit from omega-3 supplements.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia#1351392
- Irish Omega-3 Study#857167
- Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults#1365490
- The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis#1214580
- Varenicline Adjunctive Treatment in Schizophrenia#1365935
Record · ID 1371402
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive